FDA asks for more info on COPD drug

(ABC News) UPDATED 2009-10-19

The U.S. Food and Drug Administration has asked drugmaker Novartis for more data on their experimental COPD medication. The drug--known as QAB149, or indacaterol--is a once-daily bronchodilator for patients who have emphysema or chronic bronchitis. The drug was recently approved in Europe, and a drugmaker spokesperson said the company felt confident it could address the FDA's concerns. Read full story >

See all COPD News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA asks for more info on COPD drug

People who read this also read...

What the community is saying...

New Medication Available for People Who Have Moderate to Severe COPD

Kathi MacNaughton